You just read:

Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic

News provided by

Enteris BioPharma, Inc.

30 Jan, 2017, 08:00 ET